Abstract
The parathyroid hormone (PTH) type 1 receptor (PTHR) is a medically important G protein-coupled receptor (GPCR) that triggers the cAMP/PKA signaling pathway in kidney and bone cells to regulate calcium ion homeostasis and bone turnover. It has been generally assumed that the production of cAMP mediated by GPCR and its termination take place exclusively at the plasma membrane. Recent studies reveal that the PTHR does not always follow this conventional paradigm. In the new model, PTH induces a prolonged cAMP response that is derived from the internalized ligand–PTHR complex located within endosomes. This model has been recognized as a new paradigm of GPCR signaling for peptide hormones, and the PTHR is a prototypical example. In this chapter we discuss molecular, structural, and cellular mechanisms responsible for this unexpected signaling process and its biological consequences.
References
Juppner H, Abou-Samra AB, Freeman M, Kong XF, Schipani E, Richards J, Kolakowski LF Jr, Hock J, Potts JT Jr, Kronenberg HM et al (1991) A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254:1024–1026
Gardella TJ, Vilardaga JP (2015) International Union of Basic and Clinical Pharmacology. XCIII. The parathyroid hormone receptors – family B G protein-coupled receptors. Pharmacol Rev 67:310–337
Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434–1441
Ferrandon S, Feinstein TN, Castro M, Wang B, Bouley R, Potts JT, Gardella TJ, Vilardaga JP (2009) Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. Nat Chem Biol 5:734–742
Dean T, Vilardaga JP, Potts JT Jr, Gardella TJ (2008) Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH/PTHrP receptor. Mol Endocrinol 22:156–166
Hoare SR, Sullivan SK, Pahuja A, Ling N, Crowe PD, Grigoriadis DE (2003) Conformational states of the corticotropin releasing factor 1 (CRF1) receptor: detection, and pharmacological evaluation by peptide ligands. Peptides 24:1881–1897
Vilardaga JP, Gardella TJ, Wehbi VL, Feinstein TN (2012) Non-canonical signaling of the PTH receptor. Trends Pharmacol Sci 33:423–431
Feinstein TN, Yui N, Webber MJ, Wehbi VL, Stevenson HP, King JD Jr, Hallows KR, Brown D, Bouley R, Vilardaga JP (2013) Noncanonical control of vasopressin receptor type 2 signaling by retromer and arrestin. J Biol Chem 288:27849–27860
Marx UC, Austermann S, Bayer P, Adermann K, Ejchart A, Sticht H, Walter S, Schmid FX, Jaenicke R, Forssmann WG et al (1995) Structure of human parathyroid hormone 1-37 in solution. J Biol Chem 270:15194–15202
Weidler M, Marx UC, Seidel G, Schafer W, Hoffmann E, Esswein A, Rosch P (1999) The structure of human parathyroid hormone-related protein(1-34) in near-physiological solution. FEBS Lett 444:239–244
Pioszak AA, Parker NR, Gardella TJ, Xu HE (2009) Structural basis for parathyroid hormone-related protein binding to the parathyroid hormone receptor and design of conformation-selective peptides. J Biol Chem 284:28382–28391
Pioszak AA, Xu HE (2008) Molecular recognition of parathyroid hormone by its G protein-coupled receptor. Proc Natl Acad Sci U S A 105:5034–5039
Bisello A, Adams AE, Mierke DF, Pellegrini M, Rosenblatt M, Suva LJ, Chorev M (1998) Parathyroid hormone-receptor interactions identified directly by photocross-linking and molecular modeling studies. J Biol Chem 273:22498–22505
Adams AE, Bisello A, Chorev M, Rosenblatt M, Suva LJ (1998) Arginine 186 in the extracellular N-terminal region of the human parathyroid hormone 1 receptor is essential for contact with position 13 of the hormone. Mol Endocrinol 12:1673–1683
Behar V, Bisello A, Bitan G, Rosenblatt M, Chorev M (2000) Photoaffinity cross-linking identifies differences in the interactions of an agonist and an antagonist with the parathyroid hormone/parathyroid hormone-related protein receptor. J Biol Chem 275:9–17
Shimizu M, Carter PH, Gardella TJ (2000) Autoactivation of type-1 parathyroid hormone receptors containing a tethered ligand. J Biol Chem 275:19456–19460
Gensure RC, Carter PH, Petroni BD, Juppner H, Gardella TJ (2001) Identification of determinants of inverse agonism in a constitutively active parathyroid hormone/parathyroid hormone-related peptide receptor by photoaffinity cross-linking and mutational analysis. J Biol Chem 276:42692–42699
Gensure RC, Gardella TJ, Juppner H (2001) Multiple sites of contact between the carboxyl-terminal binding domain of PTHrP-(1–36) analogs and the amino-terminal extracellular domain of the PTH/PTHrP receptor identified by photoaffinity cross-linking. J Biol Chem 276:28650–28658
Siu FY, He M, de Graaf C, Han GW, Yang D, Zhang Z, Zhou C, Xu Q, Wacker D, Joseph JS, Liu W, Lau J, Cherezov V, Katritch V, Wang MW, Stevens RC (2013) Structure of the human glucagon class B G-protein-coupled receptor. Nature 499:444–449
Hollenstein K, Kean J, Bortolato A, Cheng RK, Dore AS, Jazayeri A, Cooke RM, Weir M, Marshall FH (2013) Structure of class B GPCR corticotropin-releasing factor receptor 1. Nature 499:438–443
Jin L, Briggs SL, Chandrasekhar S, Chirgadze NY, Clawson DK, Schevitz RW, Smiley DL, Tashjian AH, Zhang F (2000) Crystal structure of human parathyroid hormone 1-34 at 0.9-A resolution. J Biol Chem 275:27238–27244
Shimizu N, Guo J, Gardella TJ (2001) Parathyroid hormone (PTH)-(1-14) and -(1-11) analogs conformationally constrained by alpha-aminoisobutyric acid mediate full agonist responses via the juxtamembrane region of the PTH-1 receptor. J Biol Chem 276:49003–49012
Tsomaia N, Pellegrini M, Hyde K, Gardella TJ, Mierke DF (2004) Toward parathyroid hormone minimization: conformational studies of cyclic PTH(1-14) analogues. Biochemistry 43:690–699
Barazza A, Wittelsberger A, Fiori N, Schievano E, Mammi S, Toniolo C, Alexander JM, Rosenblatt M, Peggion E, Chorev M (2005) Bioactive N-terminal undecapeptides derived from parathyroid hormone: the role of alpha-helicity. J Pept Res 65:23–35
Fiori N, Caporale A, Schievano E, Mammi S, Geyer A, Tremmel P, Wittelsberger A, Woznica I, Chorev M, Peggion E (2007) Structure-function relationship studies of PTH(1-11) analogues containing sterically hindered dipeptide mimetics. J Pept Sci 13:504–512
Caporale A, Biondi B, Schievano E, Wittelsberger A, Mammi S, Peggion E (2009) Structure-function relationship studies of PTH(1-11) analogues containing D-amino acids. Eur J Pharmacol 611:1–7
Caporale A, Fiori N, Schievano E, Wittelsberger A, Mammi S, Chorev M, Peggion E (2009) Structure-function relationship study of parathyroid hormone (1-11) analogues containing D-AA. Adv Exp Med Biol 611:113–114
Caporale A, Sturlese M, Gesiot L, Zanta F, Wittelsberger A, Cabrele C (2010) Side chain cyclization based on serine residues: synthesis, structure, and activity of a novel cyclic analogue of the parathyroid hormone fragment 1-11. J Med Chem 53:8072–8079
Cupp ME, Song B, Kibler P, Raghavender US, Nayak SK, Thomsen W, Galande AK (2013) Investigating hydrophobic ligand-receptor interactions in parathyroid hormone receptor using peptide probes. J Pept Sci 19:337–344
Chorev M, Goldman ME, McKee RL, Roubini E, Levy JJ, Gay CT, Reagan JE, Fisher JE, Caporale LH, Golub EE et al (1990) Modifications of position 12 in parathyroid hormone and parathyroid hormone related protein: toward the design of highly potent antagonists. Biochemistry 29:1580–1586
Yang L, Yang D, de Graaf C, Moeller A, West GM, Dharmarajan V, Wang C, Siu FY, Song G, Reedtz-Runge S, Pascal BD, Wu B, Potter CS, Zhou H, Griffin PR, Carragher B, Yang H, Wang MW, Stevens RC, Jiang H (2015) Conformational states of the full-length glucagon receptor. Nat Commun 6:7859
Dean T, Linglart A, Mahon MJ, Bastepe M, Juppner H, Potts JT Jr, Gardella TJ (2006) Mechanisms of ligand binding to the parathyroid hormone (PTH)/PTH-related protein receptor: selectivity of a modified PTH(1-15) radioligand for GalphaS-coupled receptor conformations. Mol Endocrinol 20:931–943
Feinstein TN, Wehbi VL, Ardura JA, Wheeler DS, Ferrandon S, Gardella TJ, Vilardaga JP (2011) Retromer terminates the generation of cAMP by internalized PTH receptors. Nat Chem Biol 7:278–284
Wehbi VL, Stevenson HP, Feinstein TN, Calero G, Romero G, Vilardaga JP (2013) Noncanonical GPCR signaling arising from a PTH receptor-arrestin-Gbetagamma complex. Proc Natl Acad Sci U S A 110:1530–1535
Kang Y, Zhou XE, Gao X, He Y, Liu W, Ishchenko A, Barty A, White TA, Yefanov O, Han GW, Xu Q, de Waal PW, Ke J, Tan MH, Zhang C, Moeller A, West GM, Pascal BD, Van Eps N, Caro LN, Vishnivetskiy SA, Lee RJ, Suino-Powell KM, Gu X, Pal K, Ma J, Zhi X, Boutet S, Williams GJ, Messerschmidt M, Gati C, Zatsepin NA, Wang D, James D, Basu S, Roy-Chowdhury S, Conrad CE, Coe J, Liu H, Lisova S, Kupitz C, Grotjohann I, Fromme R, Jiang Y, Tan M, Yang H, Li J, Wang M, Zheng Z, Li D, Howe N, Zhao Y, Standfuss J, Diederichs K, Dong Y, Potter CS, Carragher B, Caffrey M, Jiang H, Chapman HN, Spence JC, Fromme P, Weierstall U, Ernst OP, Katritch V, Gurevich VV, Griffin PR, Hubbell WL, Stevens RC, Cherezov V, Melcher K, Xu HE (2015) Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser. Nature 523:561–567
Burda P, Padilla SM, Sarkar S, Emr SD (2002) Retromer function in endosome-to-Golgi retrograde transport is regulated by the yeast Vps34 PtdIns 3-kinase. J Cell Sci 115:3889–3900
Collins BM (2008) The structure and function of the retromer protein complex. Traffic 9:1811–1822
Temkin P, Lauffer B, Jager S, Cimermancic P, Krogan NJ, von Zastrow M (2011) SNX27 mediates retromer tubule entry and endosome-to-plasma membrane trafficking of signalling receptors. Nat Cell Biol 13:715–721
Shi H, Rojas R, Bonifacino JS, Hurley JH (2006) The retromer subunit Vps26 has an arrestin fold and binds Vps35 through its C-terminal domain. Nat Struct Mol Biol 13:540–548
Gidon A, Al-Bataineh MM, Jean-Alphonse FG, Stevenson HP, Watanabe T, Louet C, Khatri A, Calero G, Pastor-Soler NM, Gardella TJ, Vilardaga JP (2014) Endosomal GPCR signaling turned off by negative feedback actions of PKA and v-ATPase. Nat Chem Biol 10:707–709
Okazaki M, Ferrandon S, Vilardaga JP, Bouxsein ML, Potts JT Jr, Gardella TJ (2008) Prolonged signaling at the parathyroid hormone receptor by peptide ligands targeted to a specific receptor conformation. Proc Natl Acad Sci U S A 105:16525–16530
National Center for Advancing Translational Sciences (2014) Long-acting parathyroid hormone analogs for treatment of hypoparathyroidism. http://www.ncats.nih.gov/research/reengineering/bridgs/projects/parathyroid.html
Hattersley G, Dean T, Corbin BA, Bahar H, Gardella TJ (2015) Binding selectivity of abaloparatide for PTH-type-1-receptor conformations and effects on downstream signaling. Endocrinology 157(1):141–149
Vilardaga JP, Jean-Alphonse FG, Gardella TJ (2014) Endosomal generation of cAMP in GPCR signaling. Nat Chem Biol 10:700–706
Kotowski SJ, Hopf FW, Seif T, Bonci A, von Zastrow M (2011) Endocytosis promotes rapid dopaminergic signaling. Neuron 71:278–290
Acknowledgments
This work was supported by the National Institutes of Health (NIH) under Award numbers R01 DK087688 and R01 DK102495 (JPV), and the Cotswold Foundation Fellowship Award (FJA).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Sutkeviciute, I., Jean-Alphonse, F.G., Vilardaga, JP. (2017). Endosomal PTH Receptor Signaling Through cAMP and Its Consequence for Human Medicine. In: Lebon, G. (eds) Structure and Function of GPCRs. Topics in Medicinal Chemistry, vol 30. Springer, Cham. https://doi.org/10.1007/7355_2017_1
Download citation
DOI: https://doi.org/10.1007/7355_2017_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-24589-4
Online ISBN: 978-3-030-24591-7
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)